The 13th IMPACCT Real-World Evidence Summit
The 13th IMPACCT Real-World Evidence Summit returned to Boston as the only industry-led forum providing attendees with the cutting-edge case studies and strategic insights to advance RWE utility.
In October 2025, delegates joined industry-leading experts across top pharma and biotech companies to discuss best practices to improve RWE efficiency and accuracy, address limitations and challenges in data linkage, and foster cross-functional relationships, to refine your RWE strategy.
Discover What You Missed in 2025:
Cutting-edge tools including AI modeling and tokenization to enrich clinical data, extend follow-up, and support long-term evidence needs
Attendees discovered how to design studies and structure data that meets payer and HTA expectations for credibility and transparency
Connecting disparate datasets across markets and systems, to deliver impactful, scalable, and privacy-preserving RWE insights
Applying RWD from early clinical development through to post-market access, to streamline decision-making and reduce time to market
Attending Companies Included